Cost-effectiveness of the add-on exenatide to conventional treatment in patients with parkinson’s disease when considering the coexisting effects of diabetes mellitus

HIGHLIGHTS

• who: Hsuan-Chih Chen and colleagues from the Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan have published the research: Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinsonu2019s disease when considering the coexisting effects of diabetes mellitus, in the Journal: PLOS ONE of December/12,/2021
• what: The average income was retrieved from the Survey of Family Income and Expenditure in 2015, and income of 65 years and above was used on account of the characteristics of older age in PD . The model demonstrated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.